130 related articles for article (PubMed ID: 8499979)
1. Collecting duct carcinoma of the kidney.
Dimopoulos MA; Logothetis CJ; Markowitz A; Sella A; Amato R; Ro J
Br J Urol; 1993 Apr; 71(4):388-91. PubMed ID: 8499979
[TBL] [Abstract][Full Text] [Related]
2. Renal collecting (Bellini) duct carcinoma displays similar characteristics to upper tract urothelial cell carcinoma.
Orsola A; Trias I; Raventós CX; Español I; Cecchini L; Orsola I
Urology; 2005 Jan; 65(1):49-54. PubMed ID: 15667862
[TBL] [Abstract][Full Text] [Related]
3. Collecting duct carcinoma of kidney.
Srigley JR; Eble JN
Semin Diagn Pathol; 1998 Feb; 15(1):54-67. PubMed ID: 9503506
[TBL] [Abstract][Full Text] [Related]
4. [Carcinoma of the Bellini collecting duct in paediatric patients: a case report and review of the literature].
Gurrera A; Amico P; Di Cataldo A; Vasquez E; Magro G
Pathologica; 2007 Oct; 99(5):301-5. PubMed ID: 18354951
[TBL] [Abstract][Full Text] [Related]
5. Metastatic renal carcinoma long-term survivors treated with s.c. interferon-alpha and s.c. interleukin-2.
Atzpodien J; Reitz M
Cancer Biother Radiopharm; 2005 Aug; 20(4):410-6. PubMed ID: 16114989
[TBL] [Abstract][Full Text] [Related]
6. Collecting duct renal cell carcinoma: clinical study of a rare tumor.
Chao D; Zisman A; Pantuck AJ; Gitlitz BJ; Freedland SJ; Said JW; Figlin RA; Belldegrun AS
J Urol; 2002 Jan; 167(1):71-4. PubMed ID: 11743278
[TBL] [Abstract][Full Text] [Related]
7. Pilot study of interleukin-2 and lymphokine-activated killer cells combined with immunomodulatory doses of chemotherapy and sequenced with interferon alfa-2a in patients with metastatic melanoma and renal cell carcinoma.
Sznol M; Clark JW; Smith JW; Steis RG; Urba WJ; Rubinstein LV; VanderMolen LA; Janik J; Sharfman WH; Fenton RG
J Natl Cancer Inst; 1992 Jun; 84(12):929-37. PubMed ID: 1629914
[TBL] [Abstract][Full Text] [Related]
8. [A case of collecting duct carcinoma (Bellini duct carcinoma) producing carcinoembryonic antigen].
Inagaki T; Hagino K; Matsumura N; Koh M; Nishikawa T; Suzuki A; Hirano A; Shinka T
Hinyokika Kiyo; 2001 Mar; 47(3):183-6. PubMed ID: 11329960
[TBL] [Abstract][Full Text] [Related]
9. Is there a place for radical nephrectomy in the presence of metastatic collecting duct (Bellini) carcinoma?
Méjean A; Rouprêt M; Larousserie F; Hopirtean V; Thiounn N; Dufour B
J Urol; 2003 Apr; 169(4):1287-90. PubMed ID: 12629344
[TBL] [Abstract][Full Text] [Related]
10. Integrative tumor board: metastatic renal cell carcinoma: medical oncology (II).
Pandha H
Integr Cancer Ther; 2004 Mar; 3(1):29-34. PubMed ID: 15035872
[No Abstract] [Full Text] [Related]
11. Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship.
Gupta R; Billis A; Shah RB; Moch H; Osunkoya AO; Jochum W; Hes O; Bacchi CE; de Castro MG; Hansel DE; Zhou M; Vankalakunti M; Salles PG; Cabrera RA; Gown AM; Amin MB
Am J Surg Pathol; 2012 Sep; 36(9):1265-78. PubMed ID: 22895263
[TBL] [Abstract][Full Text] [Related]
12. Survival in renal cell carcinoma-a randomized evaluation of tamoxifen vs interleukin 2, alpha-interferon (leucocyte) and tamoxifen.
Henriksson R; Nilsson S; Colleen S; Wersäll P; Helsing M; Zimmerman R; Engman K
Br J Cancer; 1998 Apr; 77(8):1311-7. PubMed ID: 9579838
[TBL] [Abstract][Full Text] [Related]
13. Collecting duct carcinoma of the kidney: a report of three cases and review of the literature.
Matz LR; Latham BI; Fabian VA; Vivian JB
Pathology; 1997 Nov; 29(4):354-9. PubMed ID: 9423214
[TBL] [Abstract][Full Text] [Related]
14. Sarcomatoid collecting-duct carcinoma of the kidney.
Charfi S; Ayadi L; Ellouze S; Khabir A; Chtourou I; Gouiaa N; Bahri I; Sellami-Boudawara T
Clin Genitourin Cancer; 2007 Dec; 5(7):452-4. PubMed ID: 18272028
[TBL] [Abstract][Full Text] [Related]
15. Immunochemotherapy with interleukin-2, interferon-alpha and 5-fluorouracil for progressive metastatic renal cell carcinoma: a multicenter phase II study. Dutch Immunotherapy Working Party.
van Herpen CM; Jansen RL; Kruit WH; Hoekman K; Groenewegen G; Osanto S; De Mulder PH
Br J Cancer; 2000 Feb; 82(4):772-6. PubMed ID: 10732744
[TBL] [Abstract][Full Text] [Related]
16. Long-term remission in a patient with metastatic collecting duct carcinoma treated with taxol/carboplatin and surgery.
Gollob JA; Upton MP; DeWolf WC; Atkins MB
Urology; 2001 Dec; 58(6):1058. PubMed ID: 11744492
[TBL] [Abstract][Full Text] [Related]
17. [Impact of immunochemotherapy on survival of patients with metastatic renal cell carcinoma. A retrospective study comparing interferon-alpha-2a/vinblastine versus interferon-alpha-2a/interleukin-2/5-fluorouracil].
May M; Helke C; Bock M; Hoschke B
Urologe A; 2004 Sep; 43(9):1111-9. PubMed ID: 15232686
[TBL] [Abstract][Full Text] [Related]
18. Collecting duct carcinoma of the kidney associated with the sickle cell trait.
Yip D; Steer C; al-Nawab M; van der Walt J; Harper P
Int J Clin Pract; 2001; 55(6):415-7. PubMed ID: 11501235
[TBL] [Abstract][Full Text] [Related]
19. Collecting duct renal cell carcinoma: two different clinical stages, two different clinical outcomes.
Vázquez-Lavista LG; Uribe-Uribe N; Gabilondo-Navarro F
Urol Int; 2008; 81(1):116-8. PubMed ID: 18645283
[TBL] [Abstract][Full Text] [Related]
20. Low-grade collecting duct carcinoma of the kidney: report of 13 cases of low-grade mucinous tubulocystic renal carcinoma of possible collecting duct origin.
MacLennan GT; Farrow GM; Bostwick DG
Urology; 1997 Nov; 50(5):679-84. PubMed ID: 9372874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
